TELEPHARMACY AND VIRTUAL CARE: TRANSFORMING HEALTHCARE DELIVERY IN THE DIGITAL ERA
Keywords:
Telepharmacy, Virtual care, Telemedicine, Digital healthcare, Medication therapy management, Remote patient monitoring, Artificial intelligenceAbstract
Telepharmacy and virtual care have rapidly emerged as essential components of modern healthcare systems, fundamentally transforming the delivery of pharmaceutical and clinical services through digital technologies. Telepharmacy refers to the remote provision of pharmaceutical care using telecommunications, electronic health systems, and digital platforms, while virtual care encompasses broader healthcare services including telemedicine, remote patient monitoring, online consultations, and digital therapeutic interventions. These innovations have significantly improved healthcare accessibility, particularly in rural, underserved, and geographically isolated communities where shortages of healthcare professionals remain a persistent challenge. The global expansion of digital healthcare accelerated substantially during the COVID-19 pandemic, highlighting the importance of remote healthcare models in ensuring continuity of patient care while minimizing infection risks. Technological advancements including electronic health records, cloud computing, wearable devices, mobile health applications, artificial intelligence, and secure communication platforms have enhanced the effectiveness of telepharmacy and virtual healthcare services. Studies demonstrate improvements in medication adherence, chronic disease management, patient engagement, and healthcare efficiency through remote care interventions. Telepharmacy also supports medication therapy management, prescription verification, patient counseling, and pharmacovigilance services, reducing medication-related complications and healthcare costs. Despite these benefits, implementation challenges persist, including cyber security concerns, reimbursement limitations, regulatory inconsistencies, infrastructure disparities, and digital literacy barriers among healthcare providers and patients. Ethical concerns related to confidentiality, informed consent, and equitable healthcare access also require careful consideration.
Downloads
References
1. Alexander E, Butler CD, Darr A, Jenkins MT, Long RD, Shipman CJ, et al. ASHP statement on telepharmacy. Am J Health Syst Pharm. 2017;74:e236-41.
2. Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak. Inform Med Unlocked. 2020;20:100398.
3. Omboni S, Ferraris C, Comelli M, et al. Telemedicine and chronic disease management. Telemed J E Health. 2019;25:1094-102.
4. Dorsey ER, Topol EJ. State of telehealth. N Engl J Med. 2016;375:154-61.
5. Baldoni AO, Araujo VE, Figueiredo RC, et al. Telepharmacy services: present status and future perspectives. Res Social Adm Pharm. 2019;15:827-32.
6. Kruse CS, Karem P, Shifflett K, et al. Evaluating barriers to adopting telemedicine worldwide. J Telemed Telecare. 2018;24:4-12.
7. Wootton R. Twenty years of telemedicine. J Telemed Telecare. 2001;7:1-5.
8. Poudel A, Nissen LM. Telepharmacy: a pharmacist’s perspective. Aust J Rural Health. 2016;24:236-41.
9. Fatehi F, Samadbeik M, Kazemi A. What is digital health? BMJ Health Care Inform. 2020;27:e100275.
10. Keesara S, Jonas A, Schulman K. Covid-19 and health care’s digital revolution. N Engl J Med. 2020;382:e82.
11. Reeves JJ, Hollandsworth HM, Torriani FJ, et al. Rapid telehealth adoption during COVID-19. NEJM Catal Innov Care Deliv. 2020;1:1-13.
12. Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. Nurse Pract. 2021;46:57-62.
13. Almathami HKY, Win KT, Vlahu-Gjorgievska E. Barriers to telehealth systems. J Med Syst. 2020;44:1-9.
14. Peterson CD, Anderson HC Jr. Telepharmacy: an innovative model. Hosp Pharm. 2004;39:43-6.
15. Bashshur RL, Shannon GW, Smith BR, et al. Telemedicine evaluation framework. Telemed J E Health. 2016;22:755-63.
16. Vidal-Alaball J, Acosta-Roja R, Pastor Hernández N, et al. Telemedicine in the face of the COVID-19 pandemic. JMIR Public Health Surveill. 2020;6:e18810.
17. Iyengar K, Upadhyaya GK, Vaishya R, et al. COVID-19 and applications of digital health. Diabetes Metab Syndr. 2020;14:733-7.
18. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management. 3rd ed. New York: McGraw-Hill; 2012.
19. Viswanathan M, Kahwati LC, Golin CE, et al. Medication therapy management interventions in outpatient settings. Ann Intern Med. 2015;162:187-94.
20. Casey MM, Elias W, Knudson A, et al. Implementation of telepharmacy systems in rural hospitals. J Rural Health. 2010;26:273-8.
21. Unni EJ, Patel K. Telepharmacy during transitions of care. J Am Pharm Assoc (2003). 2021;61:e205-8.
22. Smith AC, Thomas E, Snoswell CL, et al. Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020;26:309-13.
23. Steinhubl SR, Muse ED, Topol EJ. Digital medicine and wearable technologies. Lancet. 2015;386:1905-12.
24. Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2:230-43.
25. Bukhari N, Rasheed H, Nayyer B, et al. Pharmacists at the frontline beating the COVID-19 pandemic. Res Social Adm Pharm. 2020;16:1797-9.
26. Rutledge CM, Kott K, Schweickert PA, et al. Telehealth and eHealth competencies for nursing education and practice. Nurse Educ. 2017;42:323-7.
27. Totten AM, Hansen RN, Wagner J, et al. Telehealth for acute and chronic care consultations. Evid Rep Technol Assess (Full Rep). 2019;(216):1-103.
28. Snoswell CL, Caffery LJ, Haydon HM, et al. Telehealth cost-effectiveness for hospital outpatient services: a systematic review. J Telemed Telecare. 2020;26:583-92.
29. Mehrotra A, Ray K, Brockmeyer DM, et al. Rapidly converting to “virtual practices”: outpatient care in the era of COVID-19. NEJM Catal Innov Care Deliv. 2020;1:1-5.
30. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44-56.
31. Kruse CS, Frederick B, Jacobson T, et al. Cybersecurity in healthcare: a systematic review of modern threats and trends. Technol Health Care. 2017;25:1-10.
32. Nouri S, Khoong EC, Lyles CR, et al. Addressing equity in telemedicine for chronic disease management during the COVID-19 pandemic. NEJM Catal Innov Care Deliv. 2020;1:1-13.
33. Bashshur R, Doarn CR, Frenk JM, et al. Telemedicine and the COVID-19 pandemic, lessons for the future. Telemed J E Health. 2020;26:571-3.
34. Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med. 2017;377:1585-92.
35. Orlando JF, Beard M, Kumar S. Systematic review of patient and caregivers’ satisfaction with telehealth videoconferencing as a mode of service delivery in managing patients’ health. J Med Internet Res. 2019;21:e15380.
36. Lee S, Kuo KM. Telehealth acceptance among elderly populations in healthcare: a systematic review. BMC Health Serv Res. 2021;21:1-12.
37. Wosik J, Fudim M, Cameron B, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27:957-62.
38. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679-81.
39. Greenhalgh T, Vijayaraghavan S, Wherton J, et al. Virtual online consultations: advantages and limitations (VOCAL) study. Br J Gen Pract. 2016;66:e460-6.
40. Webster P. Virtual health care in the era of COVID-19. Lancet. 2020;395:1180-1.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
(CC BY-NC)
. 